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Cyanobactins are a family of linear and cyclic peptides produced through the post-translational 
modification of short precursor peptides. A mass spectrometry-based screening of potential 
cyanobactin producers led to the discovery of a new prenylated member of this family of compounds, 
sphaerocyclamide (1), from Sphaerospermopsis sp. LEGE 00249. The sphaerocyclamide biosynthetic 
gene cluster (sph) encoding the novel macrocyclic prenylated cyanobactin, was sequenced. 
Heterologous expression of the sph gene cluster in Escherichia coli confirmed the connection between 
genomic and mass spectrometric data. Unambiguous establishment of the orientation and site of 
prenylation required the full structural elucidation of 1 using Nuclear Magnetic Resonance (NMR), which 
demonstrated that a forward prenylation occurred on the tyrosine residue. Compound 1 was tested 
in pharmacologically or ecologically relevant biological assays and revealed moderate antimicrobial 
activity towards the fouling bacterium Halomonas aquamarina CECT 5000.
Cyanobacteria, in particular those belonging to the orders Oscillatoriales and Nostocales, are a rich source of 
bioactive secondary metabolites, many of which are polyketides or non-ribosomal peptides produced on modular 
enzymatic complexes1,2. Cyanobacteria also synthesize a range of natural products through the post-translational 
modification of short precursor peptides2–7. These are termed ribosomally synthesized and post-translational 
modified peptides (RiPPs)3–5. Biosynthetic gene clusters encoding RiPPs are broadly distributed among the 
cyanobacteria phylum6. Cyanobactins are a group of cyclic and linear RiPPs of cyanobacterial origin that have 
received attention due to their reported bioactivities and the biotechnological potential of their biosynthetic path-
ways7,8. Many cyanobactins were discovered as the result of anticancer activity screening programs and have gen-
eral cytotoxicity against distinct tumor cell lines8. In addition, multidrug reversing (MDR), antiviral, antimalarial 
and allelopathic activities have been reported for these compounds7–9. Cyanobactin biosynthetic gene clusters 
encode precursor peptides that contain the core peptide sequence and act a as a substrate for post-translational 
modifications8. These commonly include heterocyclization of Cys, Ser and Thr residues, and oxidation of the 
resulting heterocycles to oxazoles and thiazoles8,10. Some cyanobactin biosynthetic pathways do not feature het-
erocyclases or oxidases and the resulting peptides do not contain such modified residues8. Isoprenoid derivatiza-
tions of Ser, Thr, Tyr or Trp residues, and more rarely N- or O-methylation8,10,11 are also sometimes reported for 
cyanobactins8,10,11. Prenylation can be forward, as observed for example in the prenylagaramides12, or reversed, as 
found for example in some aestuaramides13.
The core peptide of most cyanobactins is macrocyclized before release, although a number of highly modified 
linear cyanobactins have been reported11. The macrocyclic nature of cyanobactins makes them appealing for 
biotechnological use. Cyclic peptides have a higher permeability across membrane barriers, greater resistance 
to enzymatic degradation, enhanced bioavailability and higher affinity in receptor binding when compared to 
linear peptides14,15. However, studies regarding the bioactive potential and/or ecological role of a large fraction of 
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cyanobactins are lacking. The main reason is likely related to the low amounts of isolated compounds, which are 
not enough to fully explore their biological activity potential.
Previous efforts to detect potentially novel cyanobactin biosynthesis genes in cyanobacterial strains from the 
Blue Biotechnology and Ecotoxicology Culture Collection (LEGE CC) revealed a number of strains likely to pro-
duce new cyanobactins16. Here we report the detection, isolation, structural elucidation and biological activity of 
sphaerocyclamide, a novel cyanobactin (1, Fig. 1).
Results and Discussion
LC-MS-based detection of a prenylated cyanobactin. An LC-MS2-based search for the presence 
of prenylated cyanobactins was performed on crude extracts of cyanobacterial strains known to contain PatA 
homologues, presumably involved in the maturation of cyanobactins16. A prenylated cyanobactin candidate was 
detected (m/z 918 for [M + H]+, abundant prenyl neutral loss (m/z 68) in MS2 spectrum, see Supplementary 
Information S1) in a methanol extract of the cyanobacterium Sphaerospermopsis sp. LEGE 00249, prompting us 
to further investigate this strain.
Identification of the sph gene cluster in Sphaerospermopsis sp. LEGE 00249. An anacyclamide-like 
gene cluster was amplified from Sphaerospermopsis sp. LEGE 00249 by PCR, cloned and sequenced. The resulting 
sph gene cluster was found to encode 10 proteins (Table 1), including the SphA protease, SphG macrocyclase; SphE 
precursor peptide, SphF prenyltransferase, as well as the SphB and SphC proteins. Genes encoding a heterocyclase or 
oxidase were not detected. The SphA and SphG proteins are homologous to the proteases and macrocyclases involved 
in the biosynthesis of others cyanobactins. The SphF protein is homologous to other prenyltransferases present in 
cyanobactin pathways10,17. Likewise, SphB and SphC proteins are homologous to proteins encoded in almost all the 
cyanobactin gene clusters but with an unknown function11. The SphE precursor peptide, composed of 47 amino acids 
is highly homologous to a Nodularia spumigena precursor peptide and presents a new core sequence of eight amino 
acids (AQGVSYFP), flanked by recognition sequences RSII and RSIII18 (Fig. 2A). This information, together with the 
LC-MS data, enabled us to propose that the encoded cyanobactin is composed of a cyclic AQGVSYFP core structure 













































Figure 1. Structure of sphaerocyclamide (1).
Sphaerospermopsis sp. LEGE 00249 Blastp resultsa
Protein Predicted function Description
Identity/similarity 
(aa %) Organism Accession number
SphC Unknown Cyanobactin biosynthesis system PatC/TenC/TruC family protein 94/94 Nodularia spumigena (several strains) WP_006198022
SphB Unknown Cyanobactin biosynthesis system PatB/AcyB/McaB family protein 97/98 Nodularia spumigena (several strains) WP_0066198021
SphA N-terminal protease PatA/PatG family cyanobactin maturation protease 93/95 Nodularia spumigena CENA596 WP_063871509
SphE Precursor peptide Anacyclamide/piricyclamide family prenylated cyclic peptide 81/95 Nodularia spumigena CENA596 WP_063871506
ORF5 Putative transposase Transposase 92/93 Aphanizomenon flos-aquae 2012/KM1/D3 WP_039204680
SphF Prenyltransferase LynF/TruF/PatF family peptide O-prenyltransferase 98/98 Dolichospermum circinale AWQC131C WP_028090374
ORF6 Putative endonuclease Uma2 family endonuclease 97/98 Cuspidothrix issatschenkoi CHARLIE-1 WP_104387878
ORF7 Hypothetical protein Hypothetical protein 98/98 Dolichospermum circinale AWQC131C WP_028090379
ORF8 XisI protein XisI protein 99/99 Nodularia spumigena CCY9414 WP_006196086
SphG C-terminal protease PatA/PatG family cyanobactin maturation protease 95/97 Anabaena sp. 90 WP_015081385
Table 1. Annotation of the sph gene cluster from Sphaerospermopsis sp. LEGE 00249. aProtein-protein Blast 
against the Refseq database, accessed May 2018.
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Heterologous expression of the sph gene cluster. To confirm the involvement of the sph gene clus-
ter in the production of compound 1, the entire sph gene cluster was expressed in Escherichia coli TOP10. 
Compound 1 (m/z 918) was detected by LC-MS in the cell extracts of E. coli TOP10 carrying plasmid pC6_00249 
(which contained the sph genes), as confirmed by comparison of LC-MS and MS2 data with that of 1 found in 
Sphaerospermopsis sp. LEGE 00249 (Fig. 2B). The successful heterologous expression of 1 in E. coli confirmed that 
the sph gene cluster that we identified is responsible for the biosynthesis of this molecule.
MS-guided isolation of 1. Bioinformatics analysis coupled with MS data indicated the core amino acid 
sequence and the presence of a prenyl group. However, the precise location and orientation of the prenyl unit was 
not directly inferable from the afore-mentioned data. Two amino acids in the core sequence could potentially 
be prenylated (Tyr and Ser)5 while N-prenylation11 at the Gln residue, although unprecedented in cyanobactins, 
could not be entirely discarded. Furthermore, normal and reverse-prenylations have been documented for this 
class of compounds19. Our first approach to clarify the position of the prenyl moiety was to analyze the MS/MS 
fragmentation patterns of 1. Unfortunately, this analysis was unsuccessful (data not shown) owing to the adjacent 
positioning of Tyr and Ser in the structure of 1 and no fragmentations could unambiguously identify the precise 
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Figure 2. Biosynthesis of 1 in Sphaerospermopsis sp. LEGE 00249. (A) The sphaerocyclamide (sph) biosynthetic 
gene cluster is organized in a bidirectional operon. Genes marked in green encode conserved and hypothetical 
proteins that have no recognized or predicted function; the SphE precursor peptide is marked in dark blue. 
The genes encoding cyanobactin proteases are marked in light blue. The prenyltransferase gene is marked 
in light grey and genes commonly found in cyanobactin gene clusters but without predicted function are 
shown in dark grey. A transposase is present between sphE and sphF genes. Cyanobactin precursor peptides 
encode hypervariable amino acid core sequences. The precursor peptide core that originates 1 is shown below 
the sphE gene. (B) Comparison of the extracted ion chromatograms ([M + H]+, 1) of methanol extracts of 
Sphaerospermopsis sp. LEGE 00249 (bottom), E. coli (pC6_00249) (top) and E. coli (pC1_00249) (middle, 
negative control) and comparison of MS2 data from m/z 919 ions (corresponding to 1, [M + H]+) obtained from 
the Sphaerospermopsis sp. LEGE 00249 extract (bottom) and from E. coli (pC6_00249) (top).
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location of the prenyl group. Therefore, to fully elucidate the structure of 1, we obtained 1D and 2D NMR data 
that required prior purification of the compound. To achieve this, a methanol crude extract of Sphaerospermopsis 
sp. LEGE 00249 lyophilized cells (14.4 g, d.w.) was fractionated in a RP-SPE cartridge. The [M + H]+ ions cor-
responding to 1, from LC-MS analysis, were mostly present in a single fraction that was further separated using 
analytical-scale RP-HPLC, to yield pure 1 (1.2 mg, 0.008% d.w.) (Supplementary Information S2).
Structural elucidation of sphaerocyclamide using NMR reveals the prenylated residue. The 
1H-NMR spectrum of 1 (Supplementary Information S3 and S4) was characteristic for a peptide, with discrete 
broad signals clearly corresponding to exchangeable (NH) protons (δH 8.81-6.72), α-methine multiplets (δH ~5.0-
3.0) as well as the signature for the gem-dimethyl moiety of the prenyl group with two sharp singlets, each cor-
responding to three protons, resonating at δH 1.73 and 1.69, and revealing a forward prenylation in 1. Due to 
the low amount of material and the size of the compound, we were unable to obtain high-quality 13C-data for 1, 
although many characteristic signals were clearly discernible (Supplementary Information S3 and S5), including 
those corresponding to amide (δC 174.5-168.2), aromatic or olefinic (δC 157.2-114.4), as well as α-carbon (δC ~ 
62.5-50.0) resonances.
Extensive 2D NMR analysis, including HSQC, HMBC and COSY (Supplementary Information S3, S6–S8), 
was carried out and used to assign spin systems for all the eight amino acid moieties and for the prenyl group 
that constitute compound 1 (Fig. 3A). 1H and 13C resonances were in agreement with the values from the litera-
ture for other cyclic peptides12,20. NOE data also allowed the connectivity of the eight amino acids residues to be 
determined (Supplementary Information S3 and S9), validating the bioinformatics predictions from analysis of 
the sph biosynthetic gene cluster (Fig. 3B). The NMR analysis provided strong evidence for the prenylation of Tyr, 
chiefly by exclusion of other possible sites for this modification. COSY data correlated the Ser H217 proton (δH 
3.54) with an exchangeable proton (OH-17, δH 5.11), excluding prenylation at this position. Two exchangeable, 
COSY-correlated proton signals (NHa-7 and NHb-7, δH 7.05 and 6.61, respectively) were highly diagnostic for the 
Gln side chain amide protons. In addition, because all the peptide backbone NH protons could be assigned from 
COSY, with the exception of the Ser NH which was assigned on the basis of extensive NOE correlations to Ser 
and Val protons, the possibility of N-prenylation was dismissed. Finally, aromatic protons H23 and H30 (δH 6.83) 
from the Tyr residue were found to correlate strongly through space with the H225 (δH 4.47) protons from the 
prenyl moiety (Fig. 3B), establishing the planar structure of 1. Taking into account the absence of an epimerase 
or racemization domain within the gene cluster encoding 1, an l-configuration for all chiral amino acid residues 
was proposed and subsequently confirmed by Marfey’s analysis.
Compound 1 is structurally related to the anacyclamides, kawaguchipeptins, piricyclamides and prenylagar-
amides in that it is prenylated and lacks heterocyclized residues. Phylogenetic analysis based on the cyanobactin 
protease (Supplementary Information S10) demonstrates that the biosynthetic gene cluster of metabolite 1 is 
significantly closer to the anacyclamides than to the prenylagaramides. Known anacyclamides have between 7 
and 20 proteinogenic amino acids in their cyclic structure21. Anacyclamides are produced in low amounts and 
it remains unclear which positions on these anacyclamide cores are prenylated19. In the prenylagaramides, as in 
compound 1, the Tyr residues were found to be prenylated, so it is possible that prenylated anacyclamides con-
taining Tyr share this modified residue12. Nervertheless, given the multiple isoprenoid decorations that are found 
in cyanobactins, it is still not feasible to accurately predict, exclusively from genetic information, the type and site 
of prenylation in these peptides.
Biological activity of 1. Several bioactivities have been attributed to cyanobactins7–9. However, there is no 
biological activity reported in the literature for any of the anacyclamides or prenylagaramides. Cyanobacterial 
cyclic peptides containing only unmodified proteinogenic amino acids present some relevant pharmaceutical 
activities. Planktothrix spp. produce agardhipeptin A, a weak plasmin inhibitor22, and planktocyclin, a potent 
protease inhibitor of mammalian trypsin and α-chymotrypsin23. This cyanobacterium is also responsible for the 
production of the prenylated prenylagaramides, but no activity has been assigned to these cyclic peptides12,24. 
Microcystis aeruginosa strains produce unmodified and prenylated forms of the cyanobactin kawaguchipeptin, 
with reported antibacterial activity10,25,26, and piricyclamides27, although no bioactivity has been determined for 
the latter. We selected several bioassays to test the potential bioactivity of sphaerocyclamide. No relevant cyto-
toxic, anti-inflammatory, anti-obesity, anti-quorum sensing or allelopathic activities as well as HDAC or 20S pro-
teasome inhibition were found. Antibacterial activity towards clinically-relevant isolates was also not observed. 
However, compound 1 weakly inhibited the growth of Halomonas aquamarina (CECT 5000), a biofilm-forming 
marine biofouling bacterium. The MIC for this interaction was estimated to be 240 μg mL−1, a value above the 
highest tested concentration (128 μg mL−1, Supplementary Information S11). The corresponding EC50 value was 
23.1 μg mL−1 (25.2 μM, Supplementary Information S11). Albeit mild, this antibacterial activity is in line with 
other antifoulant natural products such as the diterpene dictyol C28 or the bromopyrrole oroidin29. Compound 1 
was more effective in inhibiting H. aquamarina than a series of natural scaffold-inspired antifouling sulfated 
compounds30. Due to the complex nature of biofouling phenomena31,32, future work will be carried out to eval-
uate whether 1 can act as an antifoulant, especially in light of the low toxicity this compounds exhibits towards 
mammalian cells.
To conclude, we herein describe the discovery of sphaerocyclamide (1), in the cyanobacterium strain 
Sphaerospermopsis sp. LEGE 00249. To our knowledge this is the first report of a cyanobactin isolated from this 
recently established genus, reassigned together with the genera Dolichospermum33 (that includes some of the 
anacyclamide-producing strains reported to date) and Cuspidothrix from the genus Anabaena. Despite their 
apparently elusive biological activities, the structural group cromprising sphaerocyclamide, piricyclamides, 
kawaguchipeptins, anacyclamides and prenylagaramides, and the cyanobactins in general are highly diverse and 
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we appear to have isolated only a small fraction of their abundance6,11. Efforts to purify and characterize novel 
members of these families are therefore warranted and may reveal novel chemistry, enzymology and bioactivity.
Methods
Cyanobacterial strain culture conditions. The freshwater strain Sphaerospermopsis sp. LEGE 00249 was 
isolated from Maranhão reservoir, Portugal (N39°03′16,6″, W7°54′42,0″)16. A culture of this strain is maintained 
in the LEGE CC in Z8 medium34 without aeration, at 20 °C, under a light/dark cycle of 14:10 h and a photon 
irradiance of approximately 10 μmol m−2 s−1. Sphaerospermopsis sp. LEGE 00249 cells were grown for approxi-
mately one month to late exponential phase with aeration at 25 °C in multiple 6 L glass flasks (containing 4 L of 
Z8 medium), under a light/dark cycle of 14:10 h and a photon irradiance of approximately 30 μmol m−2 s−1 for 
biomass extraction and subsequent isolation of 1. The cultures were harvested by centrifugation (Sorvall Legend 
RT, 4500 × g, 10 min) after reaching the stationary phase, rinsed with deionized water and lyophilized.
LC-MS-based detection of prenylated cyanobactins. Lyophilized biomass (~10 mg) from each of 


















































Figure 3. NMR-based structure analysis of 1. (A) Selected HMBC and COSY correlations establishing 
the structures of the amino acids and prenyl group of 1; (B) NOE-derived inter-residue connectivity and 
attachment of the prenyl group to the Tyr moiety.
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been previously reported16, was extracted with 1 mL of MeOH in 2-mL microcentrifuge tubes containing glass 
beads (cell disruption medium, 0.5-mm-diameter glass beads, Scientific Industries Inc.) and homogenized with 
a FastPrep cell disrupter (Bio101, Thermo Electron Corporation, Qbiogen, Inc.) for 15 s at a speed of 6.5 m s−1. 
Each sample was centrifuged for 5 min at 20,000 × g (Eppendorf Centrifuge 5840R, Eppendorf), and the super-
natant analyzed using a high-performance liquid chromatograph combined with a mass spectrometer (LC-MS) 
(Agilent 1100 series LC/MSD with Ion Trap XCT Plus and an electrospray ion source) in order to detect 
low-molecular-weight peptides. Separation of peptides was performed by HPLC equipped with a Luna C8(2) 
column (Phenomenex; 2.0 mm by 150 mm; particle size 5 μm). The mobile phase consisted of 0.1% aqueous for-
mic acid (50% solution in water; Fluka, Sigma-Aldrich) (solvent A) and 0.1% formic acid in isopropyl alcohol 
(Sigma-Aldrich) (solvent B). A gradient program from 5% to 100% of solvent B during 35 minutes was used at 
a flow rate of 0.15 mL min−1. The column was heated during separation to 40 °C and the positive-ion mode of 
electrospray ionization was used. The nebulizer gas (N2) pressure was 30 lb/in2, the flow rate of the drying gas was 
8 L min−1 and the temperature was 350 °C. The capillary voltage was set at 5,000 V, end plate offset −500 V and the 
capillary exit value was 300 V. A skimmer potential of 85 V and a trap drive value of 144 were used. Spectra were 
recorded using a scan range from m/z 100 to m/z 2,200.
Identification of the sph gene cluster in Sphaerospermopsis sp. LEGE 00249. Biomass from 
40 mL culture of Sphaerospermopsis sp. LEGE 00249 grown until exponential-phase was harvested by centrif-
ugation at 7,000 × g for 7 min (Eppendorf Centrifuge 5840R, Eppendorf). Total genomic DNA was extracted 
from the resulting pellet using a commercial kit (E.Z.N.A plant DNA mini kit, Omega Bio-Tek, Doraville, 
GA) and following the manufacturer’s procedures. The sphE peptide precursor gene was amplified using 
primers preRNAF (5′GAAG AACATCCGCCCCCAACAAGTTG3′) and preRNAR (5′CTCCGCGTCGTC 
GCCTGCAAAAGG3′) and primers PreF (5′GCCTTCACCAAACCAGTCTTCTTCAT3′) and PreR 
(5′CATCGAGGCGAACCGTGCGCCAAGGGAT3′). PCR amplifications were performed as previously 
described21. Sequencing data was obtained using the BigDye® Terminator Cycle Sequencing Ready Reaction kit 
(version 3.1) (PE Applied Biosystems) and analyzed on an ABI 3730xl automated sequencer.
The entire sph gene cluster was amplified from the genomic DNA of Sphaerospermopsis sp. LEGE 
00249 by PCR using primers acyCF (5′ATTAACACCAAATACGACCACGACGG3′) and acyGR 
(5′TTATGCTGATTTTGCCACAGACCAAGAACG3′) in six 20 μL reaction mixtures containing 5× Phusion GC 
Buffer (BioLabs Inc.), 200 μmol of each deoxynucleotide triphosphate (Thermo Fisher Scientific), 0.75 μM of each 
of the primers, 0.8 U of Phusion High-Fidelity DNA Polymerase (BioLabs Inc.), and 61.9 ng of Sphaerospermospsis 
sp. LEGE 00249 template DNA. The thermal cycling conditions were as follows: 94 °C for 3 min, followed by 30 
cycles of 94 °C for 30 s, 53.1 °C for 30 s, and 68 °C for 11 min and then a final extension at 68 °C for 20 min. The 
PCR products were separated in a 0.6% agarose gel in 0.5× TAE buffer stained with SYBR Safe DNA gel stain 
(Invitrogen) and visualized using a Dark reader (Clare Chemical Research Inc.) to avoid DNA cross-linking 
from UV light during gel excision. The 10-kb PCR product was gel extracted using the MinElute gel extraction 
kit (Qiagen) and cloned into the pCRTM2.1-TOPO vector using a TOPO TA cloning kit (Invitrogen) with an 
insert-to-vector ratio of 3:1. Chemically competent Escherichia coli One Shot TOP 10 cells (Invitrogen) were 
transformed with the vector according to the manufacturer’s instructions. The resultant plasmids (pC4_00249, 
pC6_00249, pC7_00249, pC8_00249 and pC16_00249) were analyzed by PCR and restriction enzyme digestions 
were carried out to ensure the maintenance and integrity of the insert during cloning and amplification in E. 
coli. The transformants containing the sph gene cluster insert in the plasmid were grown overnight with shaking 
at 120 rpm at 37 °C in 50 mL of LB medium containing 100 μg mL −1 of ampicillin (sodium salt; Sigma-Aldrich) 
for LC-MS analysis. The cells (33.4–41.4 mg) were harvested by centrifugation at 7,000 × g for 7 min (Eppendorf 
Centrifuge 5840 R, Eppendorf), extracted with MeOH and the resulting extracts were directly analyzed by LC-MS 
as detailed for cyanobacterial cell extracts. Plasmid pC6_00249 was sequenced and the sph gene cluster was 
obtained after LC-MS analyses of E. coli transformed cells. The gene cluster was manually annotated in Artemis 
(Sanger Institute) using a combination of BLASTp and CD (Conserved Domains) database searches. Glimmer 
was used for open reading frame (ORF) predictions and BLASTp was performed to evaluate the functional anal-
ysis of the proteins. The predictions for start sites of the genes were checked manually. The annotated sequence 
of the sph gene cluster from Sphaerospermopsis sp. LEGE 00249 was deposited in GenBank under the accession 
number MF140698.
Extraction and LC-MS-Guided Isolation of 1. Lyophilized biomass (14.4 g, d.w.) of the cyanobacterium 
Sphaerospermopsis sp. LEGE 00249 was repeatedly extracted with MeOH yielding 2.6 g of crude extract. A por-
tion of the crude extract (0.80 g) was fractionated using a C18-E SPE cartridge (50 g, Strata, Phenomenex) with a 
stepwise gradient from 10% MeCN (aq) to 100% MeCN to 100% acetone, yielding eighteen fractions. These were 
subjected to Electrospray Ionization (ESI) LC-ESI-MS profiling (Alliance e2695 separations module coupled to 
a Micromass Quattro Micro Api™ detector) in order to search for the predicted mass of 1 (m/z 918) [M + H]+. 
Separation was performed by HPLC equipped with an Aeris Peptide C18 column (Phenomenex; 4.6 mm by 
150 mm; particle size, 3.6 μm). The mobile phase consisted of MeCN (solvent A) and MilliQ water (solvent B) 
both acidified with 0.1% formic acid. A linear gradient program from 5% to 70% of solvent A during 20 minutes, 
and then returning to the initial conditions in a total run time for 30 min, was used at a flow rate of 0.15 mL min−1. 
The column was heated during separation to 25 °C and the positive-ion mode of electrospray ionization was used. 
The nebulizer gas (N2) flow rate was 500 liters hr−1 and the desolvation temperature was 250 °C. Spectra were 
recorded using single ion recording (SIR) of m/z 918 in a scan range from m/z 30 to 1000. Collected data was 
interpreted using MassLynnx™ software (Waters).
One of the fractions (13.1 mg), eluting with 50% MeCN (aq), presented the highest amount of 1 
(Supplementary Information S2) and was therefore further separated by HPLC (using a system composed 
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of a 1525 pump coupled to a 2487 UV-Vis detector, Waters) fitted with a Synergy 4 μ Fusion RP-80A column 
(Phenomenex; 4.6 mm by 250 mm; particle size 4 μm). A gradient program from 5% MeCN (aq) to 100% MeCN 
during 35 minutes, then held for 5 minutes before returning to the initial conditions over 5 minutes, was used 
with a flow rate of 1 mL min−1 and the separation was monitored at two different wavelengths (235 and 280 nm). 
The resulting fractions were submitted to LC-ESI-MS analysis, in order to search for the presence of 1. Analysis 
conditions were as previously described for the analysis of the SPE fractions, with the exception of the gradient 
program, that consisted in an increase from 40% to 80% of solvent A during 10 minutes, and then returning to the 
initial conditions in a total run time for 15 minutes, at flow rate of 0.3 ml min−1. One of the HPLC subfractions 
(tR = 19. 5 min) presented the correspondent predicted mass (Supplementary Information S2). Therefore, suc-
cessive rounds of HPLC separation as described above were performed until 1 was obtained (1.2 mg, 0.03% d.w.) 
with enough purity for structural analysis and bioactivity testing.
Sphaerocyclamide (1): white amorphous solid; UV (MeOH) λmax (log ε) 206 (3.8), 226 (3.6), 268 (3.0), 278 
(3.0) nm; 1H, 13C NMR, HMBC, COSY and NOESY data see Supplementary Information S3–S9; HRESIMS (see 
Supplementary Information S12) m/z 940.4545 [M + Na]+ (calcd for C46H63N9O11Na+, 940.4539).
UV-Vis data was acquired on a microplate reader (Synergy HT, Biotek, USA). Optical rotation data was meas-
ured (average of ten replicates) on a Jasco P-2000 polarimeter at a wavelength of 589 nm using a 1 mL cell. NMR 
data were acquired in a 600 MHz Bruker Avance III equipped with a 5 mm cryoprobe. NMR spectra were refer-
enced to the residual solvent 1H and 13C signals (δH 2.500 and δC 39.52 for DMSO, respectively). High-resolution 
mass spectrometry was performed on a LTQ Orbitrap XL spectrometer, controlled by LTQ Tune Plus 2.5.5. and 
Xcalibur 2.1 (Thermo Scientific). The capillary voltage of the ESI was set to 2800 V. The capillary temperature 
was 300 °C. The sheath gas and auxiliary gas flow rate (nitrogen) were set to 40 and 10 (arbitrary unit as provided 
by the software settings). The capillary voltage was −48 V and the tube lens voltage −247.79 V. The sample was 
injected at a concentration of approximately 50 μg mL−1. All solvents used were LC-MS-grade or HPLC-gradient 
grade for LC-MS-based experiments, HPLC gradient for HPLC analysis/purification and ACS grade for extrac-
tion and SPE, unless stated otherwise. NMR solvents were acquired either from Sigma-Aldrich or BDH Prolabo 
(VWR).
Absolute configuration of 1. A hydrolysate of compound 1 (0.4 mg, 6 N HCl, 110 °C, 24 h) was dried under 
a N2 stream and dissolved in 50 μL of water before 20 μL of 1 M NaHCO3 was added. One-hundred microliters 
of a 1-fluoro-2,4-dinitrophenyl-5-l-alanine amide (FDAA, Marfey’s Reagent) solution in acetone (1%, w/v) was 
added and the mixture was incubated for 1 h at 37 °C. The reaction was stopped with 20 μL 1 M HCl. The analysis 
of FDAA amino acid derivatives was carried out with LCMS (Waters Acquity UPLC and Synapt G2-Si QTOF). 
A Kinetex® 1.7 µm C8 100 Å, LC Column 50 × 2.1 mm was used with a gradient of solutions A (0.1% HCOOH 
in water) and B (0.1% HCOOH in 2-propanol/acetonitrile 1:1). B was changed from 5% to 60% in 6.00 min then 
the column was washed with 100% of B for 2.00 min and equilibrated in 5% of B for 2.00 min. The retention 
times observed for the [M + Na]+ adducts of the FDAA amino acid derivatives of hydrolysate and standards (in 
brackets) were as follows: 2.80 min (d-Ala 3.12 min, l-Ala 2.80 min); 2.61 min (d-Glu 2.81 min, l-Glu 2.62 min); 
2.45 min (Gly 2.44 min); 3.65 min (d-Val 4.09 min, l-Val 3.65 min); 2.17 min (d-Ser 2.21 min, l-Ser 2.17 min); 
3.20 min (d-Tyr 3.40 min, l-Tyr 3.21 min); 4.01 min (d-Phe 4.36 min, l-Phe 4.01 min); 2.87 min (d-Pro 2.97 min, 
l-Pro 2.88 min).
Biological activity evaluation of 1. Preparation of stock solutions. Stock solutions of 1 were prepared 
in DMSO (cell culture grade, Sigma-Aldrich) at 1 and 3 mg mL−1 and used in several bioassays. For MIC deter-
mination, DMSO stock solutions of 1 were prepared at different concentrations (0.0125–12.8 mg mL−1) by serial 
dilution.
Bioassays with fouling marine bacteria. Compound 1 was tested at a concentration of 10 μg mL−1 (11 μM) 
against five marine fouling bacteria strains, acquired from the Spanish Type Culture Collection (CECT). The bac-
teria Cobetia marina CECT 4278, Vibrio harveyi CECT 525, Roseobacter litoralis CECT 5395, Halomonas aqua-
marina CECT 5000, and Pseudoalteromonas atlantica CECT 570 were inoculated with 1 in Marine Broth (MB) 
(Difco) at an optical density (OD) 600 nm of ~0.1, in 96 well flat-bottom microtiter plates (Orange Scientific, 
Belgium), and grown at 26 °C for 24 hours. Bacterial growth in the presence of 1 was compared to the growth in 
MB medium by reading OD at 600 nm using a microplate reader (Synergy HT, Biotek, USA). An antibiotic cock-
tail (penicillin 5000 units mL−1, streptomycin 5 mg mL−1 and neomycin 10 mg mL−1, Sigma-Aldrich) was used 
as positive control whereas DMSO (1%, v/v) was used as a solvent control. When growth inhibition caused by 1 
was observed (i.e. for Halomonas aquamarina CECT 5000), dose-response curves were created and MIC values 
calculated (Gompertz equation model, bottom fit values corresponding to the positive control OD) using Prism 
7 (GraphPad Software). For comparative purposes, IC50 values were also determined (from a four-parameter 
equation fit) using the same software.
Cancer cell cytotoxicity assays, anti-inflammatory activity assays, anti-obesity activity assays, HDAC and 20S 
proteasome inhibition assays, anti-quorum sensing activity test, antibacterial activity assays using clinically-relevant 
strains and allelopathic activity assays. Please see Supplementary Information (S13).
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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